By expenditures
| Name | Title | Type |
|---|---|---|
| Suzanne Garber | Officer | Auditee |
| Sam Wehbe | Chief Financial Officer | Auditee |
| Andrea Chung | Audit Managing Director | Auditee |
| Paige Hagen | Audit Managing Director | Auditee |
| Bryce Rassilyer | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 405579 | 2025 | 2026-06-29 | CLIFTONLARSONALLEN LLP | $9.28M |
| 366111 | 2024 | 2025-09-11 | Cliftonlarsonallen LLP | $13.21M |
| 308679 | 2023 | 2024-06-12 | Kpmg | $11.63M |
| 16949 | 2022 | 2023-03-30 | Kpmg | $10.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 366111 | 2024 | 2025-09-11 | 1152639 | 2024-001 | Significant Deficiency | - | BH |
| 366111 | 2024 | 2025-09-11 | 1152638 | 2024-001 | Significant Deficiency | - | BH |
| 366111 | 2024 | 2025-09-11 | 1152637 | 2024-001 | Significant Deficiency | - | BH |
| 366111 | 2024 | 2025-09-11 | 576197 | 2024-001 | Significant Deficiency | - | BH |
| 366111 | 2024 | 2025-09-11 | 576196 | 2024-001 | Significant Deficiency | - | BH |
| 366111 | 2024 | 2025-09-11 | 576195 | 2024-001 | Significant Deficiency | - | BH |
| 308679 | 2023 | 2024-06-12 | 977082 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 977081 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 977080 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 977079 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 977078 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 977077 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 977076 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 977075 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 977074 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 977073 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 977072 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 977071 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 400640 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 400639 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 400638 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 400637 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 400636 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 400635 | 2023-002 | Material Weakness | - | C |
| 308679 | 2023 | 2024-06-12 | 400634 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 400633 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 400632 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 400631 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 400630 | 2023-001 | Significant Deficiency | - | C |
| 308679 | 2023 | 2024-06-12 | 400629 | 2023-001 | Significant Deficiency | - | C |
| 16949 | 2022 | 2023-03-30 | 588911 | 2022-001 | Significant Deficiency | - | L |
| 16949 | 2022 | 2023-03-30 | 12469 | 2022-001 | Significant Deficiency | - | L |